This inventor holds 1 USPTO granted patent. Top assignee: Via Pharmaceuticals, Inc.. Active years: 2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007
Title: Innovations of Dominique Schultz
Introduction
Dominique Schultz is an accomplished inventor based in Illkirch, France. He has made significant contributions to the field of therapeutics, particularly through his innovative work on cyclic nucleotide phosphodiesterase inhibitors.
Latest Patents
Dominique Schultz holds a patent for "Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses thereof." This invention focuses on novel benzodiazepine derivatives and their applications in treating pathologies related to the activity of cyclic nucleotide phosphodiesterase. The patent also details methods for preparing these compounds and introduces novel synthesis intermediates. The inventive compounds correspond to a specific general formula, showcasing the complexity and utility of his work.
Career Highlights
Dominique Schultz is associated with Via Pharmaceuticals, Inc., where he continues to advance his research and development efforts. His work has the potential to impact various therapeutic areas, making him a notable figure in the pharmaceutical industry.
Collaborations
He has collaborated with esteemed colleagues such as Jean-Jacques Bourguignon and Yan Lagouge, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Dominique Schultz's contributions to the field of therapeutics through his innovative patents highlight his role as a significant inventor. His work continues to pave the way for advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile